44 named partners show up behind Mako's sponsored and branded content — Isracard leads the evidence trail
Asked:
What are all the brands doing sponsored content deals with Mako.co.il
A live-web scan of Mako.co.il pages and tag indexes surfaced 44 named brands and organizations tied to sponsored, funded, partner-branded or promotional content, backed by 63 distinct evidence pages. It is an inventory of discoverable deals — many undated or older pages preserve historical partnerships — not Mako's current sales roster.
Explicit paid/funded content (6)Branded partnership — בשיתוף/בחסות (33)Promotion or prize activity (4)Partner-branded special section (1)
· bar length = distinct supporting pages found (evidence coverage, not deal value)
Isracard (ישראכרט) has the deepest evidence trail — 9 distinct pages explicitly labelled "תוכן ממומן בשיתוף" (paid content in partnership), the most recent dated January 2025. mako.co.il
Only 6 of the 44 partners carry explicit paid/funded labels such as "מוגש מטעם" or "תוכן ממומן"; the other 33 branded partnerships use the softer "בשיתוף/בחסות" disclosure, which spans commercial deals and cause collaborations. mako.co.il
Health is a visible paid-content niche: Teva, Novo Nordisk, Pfizer and the Israel Diabetes Association all appear behind funded or partnered health articles, mostly dated 2020–2021. mako.co.il
Most evidence is undated tag-index pages — 34 of 44 partners have no dated article — so many listed deals are historical or of unknown recency rather than confirmed active. mako.co.il
Evidence table — all 44 partners
Brand
Deal type
Mako label
Example content
Latest date
Pages
Source
Method: live-web scan of Mako.co.il article pages, tag indexes and special sections, collected up to 2026-09-01. 44 rows, one per normalized brand/organization; "pages" counts distinct supporting Mako pages found (evidence coverage, not deal value or campaign volume). Excluded: reporting on third-party sponsorships, song lyrics, individuals, Mako itself, and ordinary editorial mentions. Undated or older evidence marks historical/discoverable partnerships, not necessarily active deals.